New Technologies for Endoscopic Treatment of Bleeding Gastroduodenal Ulcers
NCT ID: NCT04239118
Last Updated: 2020-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
112 participants
INTERVENTIONAL
2018-01-10
2019-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Doppler-guided Endoscopic Treatment in Peptic Ulcer Bleeding
NCT02434978
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
NCT06543316
Efficacy of a Novel Hemostatic Powder in GI Bleeding
NCT02595853
Platelet Rich Plasma in Bleeding Peptic Ulcer
NCT03733171
Argon Plasma Coagulation for Bleeding Peptic Ulcers
NCT02241044
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Applications of autoplasma, enriched with platelets and
Endoscopic applications of autoplasma, enriched with platelets and granular sorbent aseptisorb-A in bleeding gastroduodenal ulcers
Complex endoscopic treatment with the use of granular sorbent aseptisorb-A and autoplasm enriched with platelets
Complex endoscopic bleeding ulcers treatment with the use of granular sorbent aseptisorb-A and autoplasm enriched with platelets
Traditional methods of endoscopic hemostasis
Traditional methods of endoscopic hemostasis were used without the use of platelet-enriched plasma and granular sorbents.
Traditional methods of endoscopic hemostasis
Traditional methods of endoscopic hemostasis were used without the use of platelet-enriched plasma and granular sorbents
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Complex endoscopic treatment with the use of granular sorbent aseptisorb-A and autoplasm enriched with platelets
Complex endoscopic bleeding ulcers treatment with the use of granular sorbent aseptisorb-A and autoplasm enriched with platelets
Traditional methods of endoscopic hemostasis
Traditional methods of endoscopic hemostasis were used without the use of platelet-enriched plasma and granular sorbents
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
44 Years
67 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Voronezh N.N. Burdenko State Medical Academy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Voronezh State Medical University
Voronezh, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Cherednikov
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.